Glycolipid derivatives, process for production of the same, intermediates for synthesis thereof, and process for production of the intermediates

Details for Australian Patent Application No. 2004210784 (hide)

Owner Daiichi Suntory Pharma Co., Ltd. Japan as Represented by President of National Center of Neurology and Psychiatry

Inventors Yamamura, Takashi; Murata, Kenji; Annoura, Hirokazu

Agent Griffith Hack

Pub. Number AU-A-2004210784

PCT Pub. Number WO2004/072091

Priority 2003-037397 14.02.03 JP

Filing date 13 February 2004

Wipo publication date 26 August 2004

International Classifications

C07C 247/10 Compounds containing azido groups

C07M 007/00

A61K 031/7032

C07C 247/04 Compounds containing azido groups

A61P 037/02 Drugs for immunological or allergic disorders

C07H 015/26 Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals

C07D 317/28 Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms

C07H 015/04 Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals

Event Publications

18 August 2005 PCT application entered the National Phase

  PCT publication WO2004/072091 Priority application(s): WO2004/072091

12 January 2006 Change of Name(s) of Applicant(s), Section 104

  Daiichi Suntory Pharma Co., Ltd.; Japan as Represented by President of National Center of Neurology and Psychiatry The name of the applicant has been changed to Japan as Represented by President of National Center of Neurology and Psychiatry; Daiichi Asubio Pharma Co., Ltd

24 May 2007 Change of Name(s) of Applicant(s), Section 104

  Japan as Represented by President of National Center of Neurology and Psychiatry; Daiichi Asubio Pharma Co., Ltd The name of the applicant has been changed to Japan as Represented by President of National Center of Neurology and Psychiatry; Asubio Pharma Co., Ltd

30 August 2007 Change of Name(s) of Applicant(s), Section 104

  Japan as Represented by President of National Center of Neurology and Psychiatry; Asubio Pharma Co., Ltd The name of the applicant has been changed to Japan as Represented by President of National Center of Neurology and Psychiatry; Asubio Pharma Co., Ltd. Change of Name(s) of Applicant(s), Section 104

9 September 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004210789-Medicinal composition

2004210782-Method of preventing water pollution and water-blocking fence